Skip to main content
Premium Trial:

Request an Annual Quote

Deltagen Raises $22.5 M For Functional Genomics

Premium

M

ENLO PARK, Calif.--Deltagen announced that it has completed a $22.5 million round of financing that was led by Boston Millennia Partners and included investments by the Sprout Group, Baccharis Capital, Crossroads, and Lombard Odier & Cie. The proceeds of the offering will enable the company to advance several new drug target discovery programs as well as finalize and fully commercialize its DeltaBase product, a database with information about mammalian genes specifically relevant to small molecule drug discovery.

Filed under

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.